Samer Al Hadidi, MD,MS,FACP (@hadidisamer) 's Twitter Profile
Samer Al Hadidi, MD,MS,FACP

@hadidisamer

Associate Professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities

ID: 774267564

linkhttps://uamshealth.com/provider/samer-a-al-hadidi/ calendar_today22-08-2012 18:49:57

6,6K Tweet

5,5K Followers

306 Following

Samer Al Hadidi, MD,MS,FACP (@hadidisamer) 's Twitter Profile Photo
Samer Al Hadidi, MD,MS,FACP
@hadidisamer

4 months ago

A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma @BloodJournal #mmsm ✅ modakafusp: immunocytokine directing interferon-α to CD38-positive cells ✅ ~1/2 with prior BCMA ttt ✅median FU: 7.6 mo ✅ORR: 41% in

A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma @BloodJournal #mmsm ✅ modakafusp: immunocytokine directing interferon-α to CD38-positive cells ✅ ~1/2 with prior BCMA ttt ✅median FU: 7.6 mo ✅ORR: 41% in